CA2005987A1 - Benzimidazole substitue ayant une action therapeutique et procede de preparation - Google Patents

Benzimidazole substitue ayant une action therapeutique et procede de preparation

Info

Publication number
CA2005987A1
CA2005987A1 CA2005987A CA2005987A CA2005987A1 CA 2005987 A1 CA2005987 A1 CA 2005987A1 CA 2005987 A CA2005987 A CA 2005987A CA 2005987 A CA2005987 A CA 2005987A CA 2005987 A1 CA2005987 A1 CA 2005987A1
Authority
CA
Canada
Prior art keywords
preparation
therapeutically active
substituted benzimidazole
active substituted
benzimidazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2005987A
Other languages
English (en)
Other versions
CA2005987C (fr
Inventor
Gunnel Elisabeth Sunden
Arne Elof Brandstrom
Per Lennart Lindberg
Carl Ingemar Starke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hassle AB
Original Assignee
Hassle AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hassle AB filed Critical Hassle AB
Publication of CA2005987A1 publication Critical patent/CA2005987A1/fr
Application granted granted Critical
Publication of CA2005987C publication Critical patent/CA2005987C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA002005987A 1988-12-22 1989-12-19 Benzimidazole substitue ayant une action therapeutique et procede de preparation Expired - Lifetime CA2005987C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE19888804628A SE8804628D0 (sv) 1988-12-22 1988-12-22 New compounds
SE8804628-9 1988-12-22

Publications (2)

Publication Number Publication Date
CA2005987A1 true CA2005987A1 (fr) 1990-06-22
CA2005987C CA2005987C (fr) 1999-04-13

Family

ID=20374309

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002005987A Expired - Lifetime CA2005987C (fr) 1988-12-22 1989-12-19 Benzimidazole substitue ayant une action therapeutique et procede de preparation

Country Status (26)

Country Link
US (1) US5019584A (fr)
EP (1) EP0451188B1 (fr)
JP (1) JP2793907B2 (fr)
CN (1) CN1028232C (fr)
AT (1) ATE110379T1 (fr)
AU (1) AU636866B2 (fr)
CA (1) CA2005987C (fr)
DD (1) DD296077A5 (fr)
DE (1) DE68917738T2 (fr)
DK (1) DK170801B1 (fr)
FI (1) FI913036A0 (fr)
GR (1) GR1000318B (fr)
HU (1) HUT57203A (fr)
IE (1) IE64850B1 (fr)
IL (1) IL92797A (fr)
LT (1) LT3981B (fr)
LV (1) LV10268B (fr)
NO (1) NO178338C (fr)
PH (1) PH27257A (fr)
PT (1) PT92647B (fr)
RO (1) RO110496B1 (fr)
RU (1) RU2070199C1 (fr)
SE (1) SE8804628D0 (fr)
WO (1) WO1990006926A1 (fr)
YU (1) YU242589A (fr)
ZA (1) ZA899796B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2083606C (fr) * 1990-06-20 2001-08-21 Arne Elof Brandstrom Derives de dialcoxypyridinylbenzimidazole; methode de preparation et utilisation en pharmacie
NZ244301A (en) * 1991-09-20 1994-08-26 Merck & Co Inc Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds
US6016044A (en) * 1995-09-11 2000-01-18 Alaris Medical Systems, Inc. Open-loop step motor control system
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
MXPA04007169A (es) * 2002-01-25 2004-10-29 Santarus Inc Suministro transmucosal de inhibidores de bomba de protones.
WO2003082858A1 (fr) * 2002-03-26 2003-10-09 Dr. Reddy's Laboratories Limited Formes cristallines de rabeprazole sodique
TWI367759B (en) * 2003-02-20 2012-07-11 Santarus Inc A novel formulation, omeprazole antacid complex-immediate release, for rapid and sustained suppression of gastric acid
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
AU2004257864A1 (en) * 2003-07-18 2005-01-27 Santarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
CA2531564C (fr) * 2003-07-18 2016-01-19 Santarus, Inc. Formulations pharmaceutiques utilisees pour inhiber une secretion acide et procede de fabrication associe
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE418966B (sv) 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE416649B (sv) 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
IN148930B (fr) 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4359465A (en) 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
US4331671A (en) * 1981-01-09 1982-05-25 Sterling Drug Inc. 5-(Pyridinyl)-1H-benzimidazoles and 1-hydroxy-6-(pyridinyl)-1H-benzimidazoles and their cardiotonic use
HU195220B (en) 1983-05-03 1988-04-28 Byk Gulden Lomberg Chem Fqb Process for production of new fluor-alkoxi-benzimidasole-derivatives and medical compositions containig them
JPS6150979A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
SE8500996D0 (sv) * 1985-03-01 1985-03-01 Haessle Ab Method of treatment
US4738975A (en) * 1985-07-02 1988-04-19 Takeda Chemical Industries, Ltd. Pyridine derivatives, and use as anti-ulcer agents
GB8610607D0 (en) * 1986-04-30 1986-06-04 Smith Kline French Lab Chemical compounds
FR2593178B1 (fr) * 1986-01-20 1988-04-29 Esteve Labor Dr Derives de 2-benzimidazolylalkylthio (ou sulfinyle ou sulfonyle) leur preparation et leur application en tant que medicaments.
JPH02501930A (ja) * 1987-10-30 1990-06-28 アクチエボラゲツト・ヘツスレ 薬学的化合物のための新規な用途

Also Published As

Publication number Publication date
DD296077A5 (de) 1991-11-21
DK122391D0 (da) 1991-06-21
IL92797A (en) 1994-12-29
DK122391A (da) 1991-06-24
CA2005987C (fr) 1999-04-13
IE894049L (en) 1990-06-22
EP0451188A1 (fr) 1991-10-16
NO178338C (no) 1996-03-06
YU242589A (en) 1991-04-30
LT3981B (en) 1996-06-25
NO912416D0 (no) 1991-06-20
ZA899796B (en) 1990-08-29
HUT57203A (en) 1991-11-28
JP2793907B2 (ja) 1998-09-03
NO178338B (no) 1995-11-27
NO912416L (no) 1991-07-31
GR890100834A (en) 1991-03-15
CN1028232C (zh) 1995-04-19
IE64850B1 (en) 1995-09-06
DE68917738T2 (de) 1994-12-22
DK170801B1 (da) 1996-01-22
PT92647A (pt) 1990-06-29
HU901085D0 (en) 1991-09-30
JPH04502462A (ja) 1992-05-07
FI913036A0 (fi) 1991-06-20
ATE110379T1 (de) 1994-09-15
SE8804628D0 (sv) 1988-12-22
EP0451188B1 (fr) 1994-08-24
RO110496B1 (ro) 1996-01-30
LV10268A (lv) 1994-10-20
LTIP1722A (en) 1995-07-25
CN1043714A (zh) 1990-07-11
LV10268B (en) 1995-02-20
PT92647B (pt) 1995-09-12
WO1990006926A1 (fr) 1990-06-28
US5019584A (en) 1991-05-28
IL92797A0 (en) 1990-09-17
GR1000318B (el) 1992-06-25
RU2070199C1 (ru) 1996-12-10
AU4817690A (en) 1990-07-10
PH27257A (en) 1993-05-04
DE68917738D1 (de) 1994-09-29
AU636866B2 (en) 1993-05-13

Similar Documents

Publication Publication Date Title
CA2005986A1 (fr) Derive de benzimidazole ayant un effet inhibiteur sur l'acide gastrique et procede de preparation correspondant
CA2005987A1 (fr) Benzimidazole substitue ayant une action therapeutique et procede de preparation
EP0221041A3 (fr) Dérivés de benzimidazole, leur préparation et leur application comme médicaments
CA2258918A1 (fr) Forme stable de medicament pour administration par voie orale, a base de derives de benzimidazole comme principe actif, et son procede de production
CA2005980A1 (fr) Derive du benzimidazole, produisant un effet inhibiteur sur l'acide gastrique; methode pour le preparer
CA2089748A1 (fr) Compositions pharmaceutiques contenant du 5-difluoromethoxy-2-[(3,4-dimethoxy-2-pyridyl) methylsulfinyl]benzimidazole et un agent anti-helicobacter pour le traitement des troublesgastro-intestinaux
IE871766L (en) 4-(aroylamino)piperidinebutanamide derivatives
HUT49590A (en) Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same as active ingredient
JO1653B1 (en) The current benzimidazole is a therapeutically active method for preparing it
EP0367509A3 (fr) Formulations
JO1664B1 (en) The compound has the effect of immobilizing gastric acid and the process of preparing it
JO1679B1 (en) A new, therapeutically active compound and method for preparing it

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed
MKEC Expiry (correction)

Effective date: 20121202